{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:49:23Z","timestamp":1789102163318,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journalofsubstanceabusetreatment.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jsat.2021.108285","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T22:50:28Z","timestamp":1610405428000},"page":"108285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of benzodiazepines and polysubstance status on repeat non-fatal drug overdoses"],"prefix":"10.1016","volume":"123","author":[{"given":"Sarah","family":"Mayberry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Nechuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthi","family":"Krishnaswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2021.108285_bb0005","series-title":"Technometrics","article-title":"Survival analysis using SAS: A practical guide","author":"Allison","year":"2010"},{"key":"10.1016\/j.jsat.2021.108285_bb0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/SAR.S108302","article-title":"Factors associated with opioid overdose: A 10-year retrospective study of patients in a large integrated health care system","volume":"7","author":"Boscarino","year":"2016","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"1","key":"10.1016\/j.jsat.2021.108285_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s40621-017-0118-7","article-title":"Risk markers for fatal and non-fatal prescription drug overdose: A meta-analysis","volume":"4","author":"Brady","year":"2017","journal-title":"Injury Epidemiology"},{"key":"10.1016\/j.jsat.2021.108285_bb0020","series-title":"CDC\u2019s opioid overdose indicator support toolkit. Guidance for building and reporting on opioid-related mortality, morbidity, and PDMP indicators","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"10.1016\/j.jsat.2021.108285_bb0025","series-title":"2019 annual surveillance drug-related risks and outcomes. Annual surveillance rerport of drug-related risks and outcomes - United States","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"10.1016\/j.jsat.2021.108285_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2014.09.001","article-title":"Patterns and correlates of non-fatal heroin overdose at 11-year follow-up: Findings from the Australian Treatment Outcome Study","author":"Darke","year":"2014","journal-title":"Drug and Alcohol Dependence."},{"key":"10.1016\/j.jsat.2021.108285_bb0035","series-title":"A DEA resource guide: 2017 edition","article-title":"Drugs of abuse","author":"Drug Enforcement Administration","year":"2017"},{"key":"10.1016\/j.jsat.2021.108285_bb0040","series-title":"Clinical Classifications Software (CCS), 2015","author":"Elixhauser","year":"2015"},{"key":"10.1016\/j.jsat.2021.108285_bb0045","series-title":"ArcGIS desktop: Release 10.6","author":"ESRI","year":"2018"},{"issue":"10","key":"10.1016\/j.jsat.2021.108285_bb0050","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","article-title":"The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013","volume":"54","author":"Florence","year":"2016","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2021.108285_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.annepidem.2019.12.001","article-title":"Using statewide death certificate data to understand trends and characteristics of polydrug overdose deaths in Tennessee, 2013\u20132017","author":"Golladay","year":"2020","journal-title":"Annals of Epidemiology."},{"key":"10.1016\/j.jsat.2021.108285_bb0060","series-title":"Beta Clinical Classifications Software (CCS) for ICD-10-CM\/PCS","author":"Healthcare Cost and Utilization Project","year":"2017"},{"key":"10.1016\/j.jsat.2021.108285_bb0065","series-title":"2013 NCHS urban-rural classification scheme for counties. Vital and health statistics, series 2: data evaluation and methods research","author":"Ingram","year":"2014"},{"issue":"1","key":"10.1016\/j.jsat.2021.108285_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0897190013515001","article-title":"Benzodiazepines: A major component in unintentional prescription drug overdoses with opioid analgesics","volume":"27","author":"Jann","year":"2014","journal-title":"Journal of Pharmacy Practice"},{"issue":"8","key":"10.1016\/j.jsat.2021.108285_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amepre.2015.03.010","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"27","author":"Jones","year":"2015","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.jsat.2021.108285_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105883","article-title":"Prescribing patterns before and after a non-fatal drug overdose using Tennessee\u2019s controlled substance monitoring database linked to hospital discharge data","author":"Krishnaswami","year":"2020","journal-title":"Preventive Medicine"},{"key":"10.1016\/j.jsat.2021.108285_bb0085","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.ss6619a1","article-title":"Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas - United States","author":"Mack","year":"2017","journal-title":"MMWR Surveillance Summaries"},{"key":"10.1016\/j.jsat.2021.108285_bb0090","article-title":"Record linkage approaches using prescription drug monitoring program and mortality data for public health analyses and epidemiologic studies","author":"Nechuta","year":"2019","journal-title":"Epidemiology."},{"key":"10.1016\/j.jsat.2021.108285_bb0095","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/NDT.S128278","article-title":"Risk of recurrent overdose associated with prescribing patterns of psychotropic medications after nonfatal overdose","volume":"13","author":"Okumura","year":"2017","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/j.jsat.2021.108285_bb0100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2018.06.004","article-title":"Risks of fatal opioid overdose during the first year following nonfatal overdose","volume":"190","author":"Olfson","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108285_bb0105","first-page":"1","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: Case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.jsat.2021.108285_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/j.1526-4637.2011.01260.x","article-title":"A history of being prescribed controlled substances and risk of drug overdose death","author":"Paulozzi","year":"2012","journal-title":"Pain Medicine."},{"issue":"11","key":"10.1016\/j.jsat.2021.108285_bb0115","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2021.108285_bb0120","series-title":"SAS version 9.4","author":"SAS Institute","year":"2012"},{"key":"10.1016\/j.jsat.2021.108285_bb0125","series-title":"DataFlux data management studio 2.7. Cary, NC","author":"SAS Institute","year":"2016"},{"key":"10.1016\/j.jsat.2021.108285_bb0130","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.jsat.2021.108285_bb0135","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: Retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.jsat.2021.108285_bb0140","author":"Tennessee Department of Health"},{"key":"10.1016\/j.jsat.2021.108285_bb0145","author":"Tennessee Department of Health"},{"key":"10.1016\/j.jsat.2021.108285_bb0150","author":"Tennessee Department of Health"},{"key":"10.1016\/j.jsat.2021.108285_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107714","article-title":"Incidence and predictors of drug overdoses among a cohort of >10,000 patients treated for substance use disorder","author":"Thylstrup","year":"2020","journal-title":"Drug and Alcohol Dependence."},{"key":"10.1016\/j.jsat.2021.108285_bb0160","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6913a3","article-title":"Nonfatal drug overdoses treated in emergency departments \u2014 United States, 2016\u20132017","author":"Vivolo-Kantor","year":"2020","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.jsat.2021.108285_bb0165","author":"Zibbell"}],"updated-by":[{"DOI":"10.1016\/j.jsat.2021.108302","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000}}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T11:22:34Z","timestamp":1613820154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221000118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":33,"alternative-id":["S0740547221000118"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108285","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jsat.2021.108302","asserted-by":"object"}]},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of benzodiazepines and polysubstance status on repeat non-fatal drug overdoses","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108285"}}